These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 21703477)

  • 1. [The future of inhaled antibiotic therapy. New products].
    Vendrell Relat M; Muñoz Castro G; Sabater Talaverano G; De Gracia Roldán J
    Arch Bronconeumol; 2011 Jun; 47 Suppl 6():30-2. PubMed ID: 21703477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Inhaled antibiotics in the treatment of noncystic fibrosis bronchiectasis].
    Martínez García MÁ; Soler Cataluña JJ; Serra PC
    Arch Bronconeumol; 2011 Jun; 47 Suppl 6():19-23. PubMed ID: 21703475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Inhaled antibiotic therapy in cystic fibrosis].
    Girón Moreno RM; Salcedo Posadas A; Mar Gómez-Punter R
    Arch Bronconeumol; 2011 Jun; 47 Suppl 6():14-8. PubMed ID: 21703474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Inhaled antibiotic therapy in other respiratory diseases].
    Baranda F; Gómez A; Gómez B
    Arch Bronconeumol; 2011 Jun; 47 Suppl 6():24-9. PubMed ID: 21703476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antibiotic inhalation in cystic fibrosis. A review of the literature].
    Steinkamp G
    Monatsschr Kinderheilkd; 1991 Feb; 139(2):73-80. PubMed ID: 1903843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Value of inhaled antibiotics in cystic fibrosis patients.
    Wunderlich P; Paul KD; Wehner J
    Acta Univ Carol Med (Praha); 1990; 36(1-4):34-6. PubMed ID: 2130713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intermittent administration of inhaled tobramycin in patients with cystic fibrosis. Cystic Fibrosis Inhaled Tobramycin Study Group.
    Ramsey BW; Pepe MS; Quan JM; Otto KL; Montgomery AB; Williams-Warren J; Vasiljev-K M; Borowitz D; Bowman CM; Marshall BC; Marshall S; Smith AL
    N Engl J Med; 1999 Jan; 340(1):23-30. PubMed ID: 9878641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhaled antibiotics for gram-negative respiratory infections.
    Hudson R; Olson Blair B
    Future Med Chem; 2011 Oct; 3(13):1663-77. PubMed ID: 21942255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhaled tobramycin in non-cystic fibrosis patients with bronchiectasis and chronic bronchial infection with Pseudomonas aeruginosa.
    Drobnic ME; Suñé P; Montoro JB; Ferrer A; Orriols R
    Ann Pharmacother; 2005 Jan; 39(1):39-44. PubMed ID: 15562142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delivery of antibiotics to the respiratory tract: an update.
    Traini D; Young PM
    Expert Opin Drug Deliv; 2009 Sep; 6(9):897-905. PubMed ID: 19637984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Inhalational antibiotic therapy in patients with cystic fibrosis and Pseudomonas infection].
    Mordasini C; Aebischer CC; Schoch OD
    Schweiz Med Wochenschr; 1997 May; 127(21):905-10. PubMed ID: 9289818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nebulized tobramycin in patients with chronic respiratory infections during clinical evolution of Wegener's granulomatosis.
    Terzano C; Taurino AE; Peona V
    Eur Rev Med Pharmacol Sci; 2001; 5(4):131-8. PubMed ID: 12067081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhaled antibiotics for lower respiratory tract infections: focus on ciprofloxacin.
    Serisier DJ
    Drugs Today (Barc); 2012 May; 48(5):339-51. PubMed ID: 22645722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Technological and behavioral strategies to reduce treatment burden and improve adherence to inhaled antibiotics in cystic fibrosis.
    Geller DE; Madge S
    Respir Med; 2011 Dec; 105 Suppl 2():S24-31. PubMed ID: 22208547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early aggressive eradication therapy for intermittent Pseudomonas aeruginosa airway colonization in cystic fibrosis patients: 15 years experience.
    Hansen CR; Pressler T; Høiby N
    J Cyst Fibros; 2008 Nov; 7(6):523-30. PubMed ID: 18693078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antibiotics in aerosols].
    Pascal S; Diot P; Lemarié E
    Rev Mal Respir; 1992; 9(2):145-53. PubMed ID: 1565827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Local administration of polymyxins into the respiratory tract for the prevention and treatment of pulmonary infections in patients without cystic fibrosis.
    Falagas ME; Kasiakou SK
    Infection; 2007 Feb; 35(1):3-10. PubMed ID: 17297582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term benefits of inhaled tobramycin in children with cystic fibrosis: first clinical observations from Poland.
    Stelmach I; Korzeniewska A; Stelmach W
    Respiration; 2008; 75(2):178-81. PubMed ID: 17435382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhaled antimicrobial therapy: from cystic fibrosis to the flu.
    O'Riordan TG
    Respir Care; 2000 Jul; 45(7):836-45. PubMed ID: 10926381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimal airway antimicrobial therapy for cystic fibrosis: the role of inhaled aztreonam lysine.
    Elborn JS; Henig NR
    Expert Opin Pharmacother; 2010 Jun; 11(8):1373-85. PubMed ID: 20426707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.